Why did 3689.HK stock spike in volume today?

Trade concentration and short-term buying interest lifted volume to **2,800** versus an average of **696**, a **4.02x** spike, often driven by news, repositioning, or pre-earnings accumulation ahead of the 26 Mar 2026 report.

What is Meyka AI's short-term forecast for 3689.HK stock?

Meyka AI's forecast model projects a monthly target of **HKD 2.62**, implying **27.18%** upside from **HKD 2.06**; forecasts are model-based projections and not guarantees.

Is Guangdong Kanghua Healthcare (3689.HK) cheap on valuation?

Yes by common metrics: PE **7.69**, PB **0.41**, EV/EBITDA **2.63** and a dividend yield near **8.00%** signal value, though earnings growth weakness and tax rate are counterweights.

What key level should traders watch on 3689.HK stock?

Watch **HKD 2.15** as an intraday resistance breakout confirmation; sustained volume above **1,500** shares supports follow-through and a potential move to the Meyka monthly target.

HK Stocks

Volume spike 3689.HK Guangdong Kanghua Healthcare HKSE Mar 2026: Near-term upside

ByHuzaifa Zahoor March 16, 2026

A volume spike pushed 3689.HK stock to HKD 2.06 at market close on 16 Mar 2026, up 3.00% for the day. Trading volume reached 2,800 shares versus an average of 696, a 4.02x increase that flagged short-term buying interest. This move came with a tight intraday range (HKD 2.05–2.15), a low float impression, and a clear connection between liquidity and price. We examine the drivers, valuation, technicals, and what the Meyka AI forecast implies for traders and investors in Hong Kong.